Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Hiroshi TOBITA"'
Autor:
Michihiro Iwaki, Hideki Fujii, Hideki Hayashi, Hidenori Toyoda, Satoshi Oeda, Hideyuki Hyogo, Miwa Kawanaka, Asahiro Morishita, Kensuke Munekage, Kazuhito Kawata, Tsubasa Tsutsumi, Koji Sawada, Tatsuji Maeshiro, Hiroshi Tobita, Yuichi Yoshida, Masafumi Naito, Asuka Araki, Shingo Arakaki, Takumi Kawaguchi, Hidenao Noritake, Masafumi Ono, Tsutomu Masaki, Satoshi Yasuda, Eiichi Tomita, Masato Yoneda, Akihiro Tokushige, Yoshihiro Kamada, Hirokazu Takahashi, Shinichiro Ueda, Shinichi Aishima, Yoshio Sumida, Atsushi Nakajima, Takeshi Okanoue
Publikováno v:
Clinical and Molecular Hepatology, Vol 30, Iss 2, Pp 225-234 (2024)
Background/Aims Metabolic dysfunction-associated steatotic liver disease (MASLD) was recently proposed as an alternative disease concept to nonalcoholic fatty liver disease (NAFLD). We aimed to investigate the prognosis of patients with biopsy-confir
Externí odkaz:
https://doaj.org/article/1c45e86853d948bb846d9cb50e10dad4
Autor:
Keita Kawakado, Kazuhisa Nakashima, Hiroshi Tobita, Mamiko Nagase, Ken Yoshihara, Mika Horie, Megumi Hamaguchi, Tamio Okimoto, Yukari Tsubata, Takeshi Isobe
Publikováno v:
Thoracic Cancer, Vol 14, Iss 13, Pp 1208-1211 (2023)
Abstract An 82‐year‐old man was treated with ipilimumab and nivolumab for malignant pleural mesothelioma. Although he was previously treated with prednisolone (1 mg/kg/day) for immune‐related adverse event (irAE) hepatitis by a previous doctor,
Externí odkaz:
https://doaj.org/article/069c49e3f4ec4a7991adac1b3b78145d
Autor:
Hidenori Toyoda, Hideki Fujii, Michihiro Iwaki, Hideki Hayashi, Satoshi Oeda, Hideyuki Hyogo, Miwa Kawanaka, Asahiro Morishita, Kensuke Munekage, Kazuhito Kawata, Sakura Yamamura, Koji Sawada, Tatsuji Maeshiro, Hiroshi Tobita, Yuichi Yoshida, Masafumi Naito, Asuka Araki, Shingo Arakaki, Takumi Kawaguchi, Hidenao Noritake, Masafumi Ono, Tsutomu Masaki, Satoshi Yasuda, Eiichi Tomita, Masato Yoneda, Norifumi Kawada, Akihiro Tokushige, Yoshihiro Kamada, Hirokazu Takahashi, Shinichiro Ueda, Shinichi Aishima, Yoshio Sumida, Atsushi Nakajima, Takeshi Okanoue
Publikováno v:
Gastro Hep Advances, Vol 2, Iss 8, Pp 1093-1102 (2023)
Background and Aims: Nonalcoholic fatty liver diseases (NAFLD) and nonalcoholic steatohepatitis (NASH) can cause hepatocellular carcinoma (HCC). We examined histological features and reported noninvasive markers/models for stratifying the risk of HCC
Externí odkaz:
https://doaj.org/article/565057de6be7408291dbc2b4ff90b031
Autor:
Jianglin Yue, Kenji Tanaka, Go Hirano, Gen Yonezawa, Misaki Shimizu, Yasunobu Iwakoshi, Hiroshi Tobita, Rintaro Koda, Yasutaka Higa, Hideki Watanabe, Katsunori Yanashima, Masanao Kamata
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-9 (2022)
Here the authors demonstrate chip-scale high-peak-power lasers by vertical integration of semiconductor and solid state laser gain mediums to reach the same maturity level as existing semiconductor lasers, which are suitable for miniaturization and c
Externí odkaz:
https://doaj.org/article/3d686c52ade54305b2abae942293c8e5
Autor:
Kazutaka Terahara, Tian-Cheng Li, Keiji Matsubayashi, Hidekatsu Sakata, Takanobu Kato, Atsushi Naganuma, Koji Ogawa, Koichi Honda, Jun Itakura, Noriyuki Akutsu, Hiroshi Tobita, Masaaki Korenaga, Tatsuya Kanto, Ryuichi Sugiyama, Ryosuke Suzuki, Isao Hamaguchi, Masanori Isogawa, Yoshimasa Takahashi
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 5 (2022)
ABSTRACT This study aimed to calibrate hepatitis E virus (HEV) serological assays. We optimized the previously developed in-house HEV antibody enzyme-linked immunosorbent assay (ELISA) by setting the cutoff with an in-house serological performance pa
Externí odkaz:
https://doaj.org/article/1626d02220dd483e8534e857d87dc847
Autor:
Hirokazu Takahashi, Miwa Kawanaka, Hideki Fujii, Michihiro Iwaki, Hideki Hayashi, Hidenori Toyoda, Satoshi Oeda, Hideyuki Hyogo, Asahiro Morishita, Kensuke Munekage, Kazuhito Kawata, Tsubasa Tsutsumi, Koji Sawada, Tatsuji Maeshiro, Hiroshi Tobita, Yuichi Yoshida, Masafumi Naito, Asuka Araki, Shingo Arakaki, Takumi Kawaguchi, Hidenao Noritake, Masafumi Ono, Tsutomu Masaki, Satoshi Yasuda, Eiichi Tomita, Masato Yoneda, Akihiro Tokushige, Yoshihiro Kamada, Shinichiro Ueda, Shinichi Aishima, Yoshio Sumida, Atsushi Nakajima, Takeshi Okanoue, Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD)
Publikováno v:
Nutrients, Vol 15, Iss 9, p 2014 (2023)
The relationship between baseline serum albumin level and long-term prognosis of patients with nonalcoholic fatty liver disease (NAFLD) remains unknown. This is a sub-analysis of the CLIONE (Clinical Outcome Nonalcoholic Fatty Liver Disease) study. T
Externí odkaz:
https://doaj.org/article/17fa6cfbf9e54fd2bb9a24ae061b8773
Autor:
Tomotaka Yazaki, Hiroshi Tobita, Shuichi Sato, Tatsuya Miyake, Masatoshi Kataoka, Shunji Ishihara
Publikováno v:
Journal of International Medical Research, Vol 50 (2022)
Objective We investigated the utility of combinational elastography with point shear wave elastography (pSWE) and real-time tissue elastography (RTE) for evaluating liver fibrosis in patients with liver injury. Methods In this prospective single-inst
Externí odkaz:
https://doaj.org/article/8852a556aefa42e0bd7b130721daf950
Autor:
Takae Okuno, Kazuhisa Nakashima, Yuki Mitarai, Masatoshi Kataoka, Hiroshi Tobita, Mamiko Nagase, Takeshi Isobe, Yukari Tsubata
Publikováno v:
Respiratory Medicine Case Reports, Vol 40, Iss , Pp 101773- (2022)
In recent years, the combination of platinum-based chemotherapy and immune checkpoint inhibitors (ICIs) has become the standard treatment for patients with lung cancer. Hepatitis is one of the common toxicities following ICI/chemotherapy. When drug-i
Externí odkaz:
https://doaj.org/article/9a5b920f3c0e46e38f5d0f876cf888fc
Autor:
Kinya Okamoto, Masahiko Koda, Toshiaki Okamoto, Takumi Onoyama, Kenichi Miyoshi, Manabu Kishina, Tomomitsu Matono, Jun Kato, Shiho Tokunaga, Takaaki Sugihara, Akira Hiramatsu, Hideyuki Hyogo, Hiroshi Tobita, Shuichi Sato, Miwa Kawanaka, Yuichi Hara, Keisuke Hino, Kazuaki Chayama, Yoshikazu Murawaki, Hajime Isomoto
Publikováno v:
PLoS ONE, Vol 15, Iss 2, p e0219412 (2020)
INTRODUCTION:Non-alcoholic fatty liver disease (NAFLD) has a wide spectrum, eventually leading to cirrhosis and hepatic carcinogenesis. We previously reported that a series of microRNAs (miRNAs) mapped in the 14q32.2 maternally imprinted gene region
Externí odkaz:
https://doaj.org/article/cc897b9b031c4932879792bf6f0c1385
Autor:
Hiroshi Tobita, MD, PhD, Shuichi Sato, MD, PhD, Tatsuya Miyake, MD, PhD, Shunji Ishihara, MD, PhD, Yoshikazu Kinoshita, MD, PhD
Publikováno v:
Current Therapeutic Research, Vol 87, Iss C, Pp 13-19 (2017)
Background: Nonalcoholic steatohepatitis (NASH) is an active form of nonalcoholic fatty liver disease. Risk factors for NASH include type 2 diabetes mellitus (T2DM) and obesity. Sodium–glucose cotransporter 2 (SGLT2) inhibitors used to treat T2DM p
Externí odkaz:
https://doaj.org/article/6fcc446b51304049bb4439d7fbb812a7